Oxygen Biotherapeutics CEO to Present at BIO International Convention in Chicago
April 27, 2010 10:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., April 27, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that the company will present at the BIO International Convention at McCormick Place in...
Oxygen Biotherapeutics Ships New Formulation of Dermacyte(TM) Oxygen Concentrate
April 22, 2010 08:30 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., April 22, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that the company has begun shipping its newly formulated Dermacyte™ Oxygen Concentrate...
Oxygen Biotherapeutics Swiss Equity Conference Presentation Now Available
April 13, 2010 09:22 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., April 13, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that the presentation made by Chairman and CEO Chris Stern at the Swiss Equity Biotech...
Oxygen Biotherapeutics CEO to Present at Swiss Equity Biotech Conference
April 07, 2010 08:30 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., April 7, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that its Chairman and CEO Chris Stern will present at the Swiss Equity Biotech Conference at...
Oxygen Biotherapeutics Now Marketing New Formulation of Dermacyte(TM) Oxygen Concentrate
March 29, 2010 08:00 ET
|
Oxygen Biotherapeutics, Inc.
DURHAM, N.C., March 29, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) today announced that the company has begun distribution for its newly formulated Dermacyte™ Oxygen...